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Introduction
Experimental objectives, methods and results
General conclusion
Salmonella infections in humans are often linked with the consumption of contaminated pork [1] [2]. Vaccination has been proposed to control Salmonella infections in pigs [1] [3] [4] 
and has already proven to be efficient in laying hens, reducing faecal shedding and internal egg contamination [5] [6]. The use of  vaccines in pigs is currently limited due to 
interference with European Salmonella serosurveillance programmes based on the detection of antibodies against the lipopolysaccharides (LPS) of Salmonella [7]. It was therefore the 
aim of this study to develop a DIVA-vaccine marker (Differentiation of Infected and Vaccinated Animals), without affecting immunization capacity of this strain, that would avoid 
interference with current LPS-ELISA based serosurveillance programmes. 
Vaccination of mice with ∆rfbA, ∆rfaL and ∆rfaJ but not ∆rfaI, ∆rfaG
and ∆rfaF induces protection in mice against a Salmonella Typhimurium infection
Pigs, immunized with the rfaJ or rfaL mutant , can be serologically differentiated from Salmonella infected animals
Figure 2: Serological results of pigs immunized with ∆rfaL, ∆rfaJ or Salmonella Typhimurium strain 
112910a, control pigs (animals that were not immunized and not infected) and pigs infected with 
Salmonella Typhimurium strain 112910a Nal20. Values are represented as a percentage compared to 
the wild type vaccinated group. 
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In conclusion, we provide proof of concept that deletions in the rfaJ or the rfaL gene in Salmonella Typhimurium strain 112910a allows differentiation of infected and vaccinated pigs in an 
LPS based ELISA without reducing the strain’s protective capacities in mice. Further research in pigs is underway.
We examined if it was possible to discriminate between the serological response induced after vaccination of pigs 
with adjuvanted bacterins of either Salmonella Typhimurium strain 112910a or one of its isogenic LPS mutant 
strains (∆rfaL ∆rfaJ). Secondly we compared this with the serological response of pigs after infection with 
Salmonella Typhimurium strain 112910a. 
Therefore, 14 piglets were randomly allocated to three vaccination groups (n = 12) and one sham-immunized 
control group (n = 2). The animals were intramuscularly immunized with one of the formalin-inactivated 
Salmonella strains (either: Salmonella Typhimurium strain 112910a, ∆rfaJ or ∆rfaL) in Freund’s incomplete 
adjuvant. To obtain sera from Salmonella Typhimurium infected piglets, one experimental group (n = 3) was orally 
inoculated with approximately 2 ͯ 107 CFU of Salmonella Typhimurium strain 112910aNal20. 
Conclusion:
Anti-Salmonella-antibody titers were detected in the serum of all immunized and infected animals, when using an 
in-house whole cell ELISA. No significant seroconversion was seen (P > 0.05) in animals immunized with inactivated 
∆rfaJ or ∆rfaL strains and in sham-immuized control animals (non immunized and non infected animals), when 
using the commercial IDEXX ELISA. Conversely, marked seroconversion occurred in pigs immunized with the 
inactivated Salmonella Typhimurium strain 112910a. Results illustrate a clear differentiation between sera from 
piglets immunized with the ∆rfaJ strain or ∆rfaL strain and sera of pigs infected with their isogenic wild type strain. 
Anti-Salmonella-antibody titers were detected in the serum of all immunized and infected animals, when using an 
in-house whole cell ELISA. Results are shown in figure 2.
Figure 1:Recovery of Salmonella bacteria from various organs of mice immunized with either Salmonella
Typhimurium, one of its isogenic LPS mutants or non immunized control animals and subsequently challenged 
with Salmonella Typhimurium strain NCTC12023Nal20. The mean of the log10 value of CFU per gram sample and 
standard deviations are shown. An asterisk refers to a significant difference with the control group (P < 0.05).
We tested whether mutations in the LPS of Salmonella Typhimurium strain 112910a  affect its protective 
capacity  against a subsequent challenge with a highly virulent strain.
For that purpose, seven groups of ten mice were immunized  via the orogastric route with 107 CFU of one 
of the LPS mutant strains (either: ∆rfbA, ∆rfaL, ∆rfaJ, ∆rfaI, ∆rfaG or ∆rfaF) or with the wild type Salmonella
Typhimurium strain 112910a. Four weeks after immunization, all mice were challenged with 108 CFU of the 
virulent Salmonella Typhimurium strain NCTC12023Nal20 by the orogastric route. Mice were euthanized nine 
days post challenge. 
Conclusion:
Oral immunization of mice with Salmonella Typhimurium strain 112910a, ∆rfbA, ∆rfaL or ∆rfaJ induced a 
significant (P < 0.05) protection against subsequent challenge with NCTC12023Nal20 in both spleen and liver 
compared to non immunized control animals. Results are shown in figure 1.
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